GlycoNet is advancing research, innovation, and training in glycomics to improve the quality of life of Canadians.

GlycoNet is a one-stop global destination focused on developing new carbohydrate-based drugs, vaccines and diagnostics, in collaboration with academic and industry organizations to address areas of unmet need through applied glycomics research. This national platform supports translational research, protection of intellectual property, novel drug development, company formation and training. The network includes over 150 researchers across Canada who focus on cancer, chronic diseases, infectious diseases, and neurodegenerative diseases.

GlycoNet is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

0
Network Investigators
0
Trained HQP
0
Funded Projects
0
Network Partners

Latest News

Sweet science: Sugar research gets $20M stronger

GlycoNet’s Associate Director Clinical Partnerships, Dr. Lara Mahal, is bringing personalized health care to reality.

Two GlycoNet Investigators named to Royal Society of Canada

From pioneering carbohydrate synthesis to studying aging and immunity, these GlycoNet researchers are recognized by the country’s oldest and most prestigious scholarly institute.

Using health economics to find a better way to screen for prostate cancer

GlycoNet scientists aim to change the way we diagnose the disease with a new blood test.

Network Members

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
fr_CAFrench en_USEnglish
Scroll to Top